Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria
- 24 April 1993
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 341 (8852), 1044-1049
- https://doi.org/10.1016/0140-6736(93)92409-m
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cardiac effects of antimalarial treatment with halofantrineThe Lancet, 1993
- High-Dose Mefloquine in the Treatment of Multidrug-Resistant Falciparum MalariaThe Journal of Infectious Diseases, 1992
- Emergence of Multidrug-Resistant Plasmodium Falciparum in Thailand: In Vitro TrackingThe American Journal of Tropical Medicine and Hygiene, 1992
- Halofantrine for the Treatment of Mefloquine Chemoprophylaxis Failures in Plasmodium Falciparum InfectionsThe American Journal of Tropical Medicine and Hygiene, 1991
- Mefloquine-resistant falciparum malaria on the Thai-Burmese borderThe Lancet, 1991
- Quantitation of Fansimef Components (Mefloquine + Sulfadoxine + Pyrimethamine) in Human Plasma by Two High-Performance Liquid Chromatographic MethodsTherapeutic Drug Monitoring, 1991
- An Improved High-Performance Liquid Chromatographic Method for the Simultaneous Measurement of Halofantrine and Desbutylhalofantrne in Human SerumTherapeutic Drug Monitoring, 1991
- Pharmacokinetics of halofantrine in man: effects of food and dose size.British Journal of Clinical Pharmacology, 1989
- EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYAThe Lancet, 1988
- CLINICAL TRIALS WITH HALOFANTRINE HYDROCHLORIDE IN MALAWIThe Lancet, 1988